Accepted for publication: Clinical utility of gene-expression profiling for tumor site origin
Menlo Park, CA, USA March 29, 2011 – An abstract entitled “Clinical utility of gene-expression profiling for tumor site origin” has been accepted for publication for the 2011 ASCO Annual Meeting, reporting results of a study by Cedar’s John Hornberger, Hialy Gutierrez, and Richard Hornberger, together with David Henner and Shawn Becker of Pathwork Diagnostics Inc., Gauri Varadhachary of MD Anderson Cancer Center, Scott Nystrom of Tufts Medical Center, Mahul Amin of Cedars Sinai, and Michael Walker of Stanford University.

